CLINICAL_TRIALS
research
· 2016-04-04
Clinical Trial Update: Cross-sectional Study for Identification and Description of Severe Asthma Patients [Phase 3]
Summary
A completed Phase 3 cross-sectional study conducted by GlaxoSmithKline to identify and describe patients with severe asthma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED